Stock Events

Stock Events

Brainstorm Cell Therapeutics (BCLI) Q3 2026 Earnings

17AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Next

-0.37

-0.31

-0.25

-0.19

Details

Expected EPS

-0.29

Actual EPS

N/A

Surprise EPS

0.29

Surprise Percent

+100%

Description

Brainstorm Cell Therapeutics (BCLI) will report earnings of for Q3 2026 on August 17, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.